670 nm light boosts mitochondrial membrane potential and reduces retinal inflammation (Kokkinopoulos et al. 2013)
670 nm light increased mitochondrial membrane potential and reduced age-related retinal inflammation via metabolic enhancement.
Two year follow-up of low-level laser therapy (LLLT) in patients with age-related macular degeneration (AMD) Koev et al. 2012
Two-year follow-up showed sustained visual improvements and slowed AMD progression with LLLT, confirming durable disease-modifying effects without adverse events.
670nm light treatment reduces complement propagation following retinal degeneration, Rutar et al., 2012.
670 nm reduced complement C3 deposition and pathway activation in retinal degeneration, attenuating inflammation and enhancing photoreceptor preservation.
Blue light induces oxidative stress and autophagy leading to RPE cell death, Cheng 2021
Age-related macular degeneration (AMD) is the progressive degeneration of the retinal pigment epithelium (RPE), retina, and choriocapillaris among elderly individuals and is the leading cause of blindness worldwide.
Five-year follow-up of low-level laser therapy (LLLT) in patients with age-related macular degeneration (AMD) K Koev et al 2018
Five-year follow-up showed sustained visual improvements and slowed AMD progression with LLLT, confirming long-term safety without adverse effects.
